Faecal haemoglobin concentration is related to severity of colorectal neoplasia

Journal of Clinical Pathology

Volumn 66, Issue 5, 2013, Pages 415-419

  Digby, Jayne ^a   Fraser, Callum G ^b   Carey, Francis A ^b   McDonald, Paula J ^a   Strachan, Judith A ^a   Diament, Robert H ^c   Balsitis, Margaret ^c   Steele, Robert J C ^b  

^a King's Cross Hospital   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c CROSSHOUSE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; COLON POLYP; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); DYSPLASIA; FECES; FEMALE; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADULT; AGED; COLORECTAL NEOPLASMS; FECES; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MASS SCREENING; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 84876761362     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2013-201445     Document Type: Article

References (17)

1. Towler B, Irwig L, Glasziou P, et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. Br Med J 1998;317: 559-65. (Pubitemid 28395924)
2. Duffy MJ, van Rossum LGM, van Turenhout ST, et al. Use of faecal markers in screening for colorectal neoplasia: a European Group on Tumor Markers (EGTM) position paper. Int J Cancer 2011;128: 3-11.
3. Steele RJC, McClements PL, Libby G, et al. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 2009;58: 530-5.
4. Steele RJC, Kostourou I, McClements P, et al. Effects of age, gender and deprivation on key performance indicators in a FOBT-based colorectal cancer screening programme. J Med Screen 2010;17: 68-74.
5. Moss SM, Campbell C, Melia J, et al. Performance measures in three rounds of the English bowel cancer screening pilot. Gut 2012;61: 101-7.
6. Goulard H, Boussac-Zarebska M, Ancelle-Park R, et al. French colorectal cancer screening pilot programme:results of the first round. J Med Screen 2008;15: 143-8.
7. Fraser CG. Fecal occult blood tests. Life savers or outdated colorectal screening tools? Clin Lab News 2011;37: 8-10.
8. Rabeneck L, Rumble RB, Thompson F, et al. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol 2012;26: 131-47.
9. Brenner H, Haug U, Hundt S. Sex differences in performance of fecal occult blood testing. Am J Gastroenterol 2010;105: 2457-64.
10. Khalid-de Bakker CA, Jonkers DM, Sanduleanu S, et al. Test performance of fecal occult blood testing and sigmoidoscopy compared with colonoscopy screening for colorectal advanced adenoma. Cancer Prev Res 2011;10: 1563-71.
11. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007;146: 244-55. (Pubitemid 351650610)
12. Fraser CG, Mathew CM, McKay K, et al. Automated immunochemical quantitation of haemoglobin in faeces collected on cards for screening for colorectal cancer. Gut 2008;57: 1256-60.
13. Ciatto S, Martinelli F, Castiglione G, et al. Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme. Br J Cancer 2007;96: 218-21. (Pubitemid 46160624)
14. Chen LS, Yen AM, Chiu SY, et al. Baseline immunochemical faecal occult blood test (iFOBT) concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncol 2011;12: 551-8.
15. Fraser CG. Screening for colorectal neoplasia with faecal tests. Lancet Oncol 2011;12: 516-17.
16. Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut 2002;51(Suppl v):v6-vv9.
17. Haug U, Kuntz KM, Knudsen AB, et al. Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia. Br J Cancer 2011;104: 1779-85.